Close

Tekmira Pharmaceuticals (TKMR) Allowed by FDA to Provide TKM-Ebola Under Expanded Access Protocols

September 22, 2014 9:21 AM EDT Send to a Friend
Tekmira Pharmaceuticals (NASDAQ: TKMR) announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment under expanded access protocols ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login